December 15, 2010 – Definiens and aycan have formed a partnership to complete the first joint project to quantify and analyze lung tumors.
Under the partnership, Definiens has combined its LungExpert with aycan’s OsiriX PRO to create a workstation that quantifies lung tumors according to RECIST and WHO guidelines and also by their volume. This new integrated solution enables efficient analysis of lesions, including automated quantification of lung tumors.
The new workstation is expected to be available in early 2011.
For more information: www.aycan.com, www.definiens.com
News | December 15, 2010